Analytical Data
-
基因名
EFNA5
- Application
-
别名
AF1; EFL5; EPLG7; GLC1M; LERK7; RAGS; AL-1; EPH-related receptor tyrosine kinase ligand 7
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P52803
-
表达区间
Gln21~Asn203
-
分子量
27kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EFNA5 (Ephrin-A5) is a critical member of the ephrin family, which plays a significant role in various biological processes, including cell adhesion, migration, and neuron guidance. Research on EFNA5 has gained considerable attention due to its involvement in developmental processes and its potential implications in various diseases, including cancer and neurological disorders. The EFNA5 protein is known to interact with Eph receptors, mediating bidirectional signaling that influences cellular behaviors. This makes EFNA5 an important target for understanding tumor microenvironments and neuronal circuitry. The generation of recombinant EFNA5 can facilitate in-depth studies of its structure-function relationships and elucidate its role in pathophysiological contexts. Investigating EFNA5's interactions and signaling pathways using reconstituted systems can help uncover its contributions to oncogenesis and neurodevelopment, paving the way for novel therapeutic strategies. Additionally, the production of this recombinant protein allows for the exploration of its potential as a biomarker in clinical settings, further enhancing our understanding of its significance in health and disease.
